Oxford Biomedica plc (OXB.L) LSE

575.00

-41(-6.66%)

Updated at June 02 04:39PM

Currency In GBp

Valuation

Market Cap690.56M
Enterprise Value700.31M
P/E Ratio-20.2
PEG Ratio-0.59
Price/Sales Ratio4.12
Price/Book Ratio6.66
Enterprise/Revenue4.18
Enterprise/EBITDA-45.66

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterDecember 31, 2025

Profitability

Profit Margin-0.18
Operating Margin-0.2

Management Effectiveness

Return On Assets-0.09
Return On Equity-0.49

Income Statement

Revenue168.74M
Revenue/Share1.59
Gross Profit65.98M
EBITDA-33.54M
Net Income-30.13M
Diluted EPS-0.27

Balance Sheet

Total Cash96.88M
Total Cash/Share0.92
Total Debt106.64M
Total Debt/Equity1.17
Current Ratio2.2
Book Value Per Share0.86

Price History

52-Week Change75.04
52-Week High962
52-Week Low305.5
Moving Average 50 Days604.74
Moving Average 200 Days646

Statistics

Average Volume265,052
Shares Outstanding120.92M
% Held by Institutions2.36

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:50
Last Split DateMay 30, 2018